Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-25 @ 5:20 PM
Study NCT ID:
NCT05498792
Status:
RECRUITING
Last Update Posted:
2025-04-04
First Post:
2022-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Sponsor:
Fox Chase Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-02
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-10
First Submit QC Date:
None
Study First Post Date:
2022-08-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-04
Last Update Post Date Type:
ACTUAL